Litcius/Paper detail

Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma

Julius C. Enßle, Julia Campe, Sarah Büchel, Alina Moter, Frederic See, Katharina Grießbaum, Michael A. Rieger, Sebastian Wolf, Olivier Balló, Björn Steffen, Hubert Serve, Holger F. Rabenau, Marek Widera, Melanie Bremm, Sabine Huenecke, Sandra Ciesek, Ivana von Metzler, Evelyn Ullrich

2022Cancer Cell43 citationsDOIOpen Access PDF

Topics & Concepts

SerologyImmune systemVaccinationMultiple myelomaImmunologyVirologyMedicineComputational biologyBiologyAntibodySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesAnimal Virus Infections Studies
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma | Litcius